ABSTRACT In Caenorhabditis elegans, the differentiation and morphogenesis of the foregut are controlled by several transcriptional regulators and cell signaling events, and by PHA-1, an essential cytoplasmic protein of unknown function. Previously we have shown that LIN-35 and UBC-18-ARI-1 contribute to the regulation of pha-1 and pharyngeal development through the Zn-finger protein SUP-35/ZTF-21. Here we characterize SUP-37/ZTF-12 as an additional component of the PHA-1 network regulating pharyngeal development. SUP-37 is encoded by four distinct splice isoforms, which contain up to seven C2H2 Zn-finger domains, and is localized to the nucleus, suggesting a role in transcription. Similar to sup-35, sup-37 loss-of-function mutations can suppress both LOF mutations in pha-1 as well as synthetic-lethal double mutants, including lin-35; ubc-18, which are defective in pharyngeal development. Genetic, molecular, and expression data further indicate that SUP-37 and SUP-35 may act at a common step to control pharyngeal morphogenesis, in part through the transcriptional regulation of pha-1. Moreover, we find that SUP-35 and SUP-37 effect pharyngeal development through a mechanism that can genetically bypass the requirement for pha-1 activity. Unlike SUP-35, SUP-37 expression is not regulated by either the LIN-35 or UBC-18-ARI-1 pathways. In addition, SUP-37 carries out two essential functions that are distinct from its role in regulating pharyngeal development with SUP-35. SUP-37 is required within a subset of pharyngeal muscle cells to facilitate coordinated rhythmic pumping and in the somatic gonad to promote ovulation. These latter observations suggest that SUP-37 may be required for the orchestrated contraction of muscle cells within several tissues.
O RGAN development is a complex process that is dependent on the tight spatiotemporal coordination of signaling networks, transcription factors, and effectors of cellular morphogenesis. In Caenorhabditis elegans, the foregut, which includes the buccal cavity, pharynx, and intestinal valve cells, has proven to be a powerful model for studies of the molecular mechanisms controlling organogenesis (Mango 2007 (Mango , 2009 . Although containing only 95 nuclei in the adult, the foregut is composed of seven distinct but functionally integrated cell types, which arise from diverse embryonic lineages (Albertson and Thomson 1976; Sulston et al. 1983) . Furthermore, through autonomous control, the pharynx is capable of producing a rapid and regular pumping action that is essential for the ingestion and mechanical breakdown of food.
LIN-35/Rb, the C. elegans retinoblastoma-family ortholog, and UBC-18/UBCH7-ARI-1/AR1H1, a conserved E2-E3 ubiquitin-modification complex, function redundantly to control an early step of pharyngeal morphogenesis, termed reorientation (Fay et al. 2003; Qiu and Fay 2006) . At this stage during normal development, the anteriormost cells of the pharyngeal primordium change from a radial configuration (with alignment along the rostrocaudal axis) to a parallel orientation, relative to the dorsoventral axis of the embryo (Portereiko and Mango 2001) . At the same time, the apicobasal polarities of the leading anterior cells shift from 30°to 90°to align their axes with the dorsoventral axis. These morphological changes ultimately facilitate the formation of a contiguous epithelial tube composed of pharyngeal cells and cells of the future buccal cavity (mouth). Misexecution of this step leads to a failure of the pharynx to attach to the buccal cavity (the Pun phenotype, for Pharynx unattached), together with concomitant defects in pharyngeal elongation (Fay et al. 2003; Portereiko et al. 2004) .
We recently proposed a mechanism to account for the role of LIN-35 and UBC-18-ARI-1 in pharyngeal development (Mani and Fay 2009 ). Specifically, LIN-35 and UBC-18-ARI-1 mutually inhibit the expression of SUP-35/ZTF-21, a Zn-finger protein. In the case of LIN-35, repression of SUP-35 occurs at the level of transcription and is carried out in conjunction with members of an evolutionarily conserved transcriptional repressor complex that contains E2F (Fay et al. 2004; Fay and Yochem 2007; van den Heuvel and Dyson 2008) . In contrast, UBC-18-ARI-1 inhibits SUP-35 post-transcriptionally, most likely at the level of protein stability, through ubiquitin-mediated proteolysis (Mani and Fay 2009 ). SUP-35 in turn functions to transcriptionally repress the expression of PHA-1, a novel protein required for pharyngeal development (Schnabel and Schnabel 1990; Granato et al. 1994a; Fay et al. 2004) . Thus, in lin-35; ubc-18 double mutants, SUP-35 protein levels are elevated because of the loss of two negative regulators, which leads to a reduction in PHA-1 and subsequent defects (Mani and Fay 2009) . Consistent with this model, loss of SUP-35 activity can suppress the synthetic lethal phenotype of lin-35; ubc-18 double mutants as well as lethality associated with partial loss-of-function (LOF) alleles of pha-1 (Mani and Fay 2009 ). Conversely, overexpression of SUP-35 in wild-type animals induces pharyngeal defects that phenocopy pha-1 LOF mutations. Furthermore, pharyngeal defects induced by SUP-35 overexpression are observed only in the presence of wildtype SUP-36 and SUP-37, and sup-36 and sup-37 LOF mutants suppress the synthetic lethality of lin-35; ubc-18 double mutants as well as pha-1 partial LOF mutations (Schnabel et al. 1991; Fay et al. 2004; Mani and Fay 2009 ). These findings link SUP-35, SUP-36, and SUP-37 as functional members of a regulatory module involved in the control of pharyngeal development in conjunction with PHA-1.
Here we show that SUP-37/ZTF-12, a C2H2 Zn-finger protein, acts with SUP-35 to control pharyngeal development in part through the regulation of pha-1. However, newly acquired genetic data using null alleles of pha-1 demonstrate that the relationship between PHA-1, SUP-35, and SUP-37 must also involve a mechanism that is independent of pha-1 transcriptional regulation. We also find that, in addition to its role in pharyngeal development, SUP-37 functions independently of SUP-35 to regulate two essential processes that share a common feature of involving the coordinated contraction of muscle cells.
Materials and Methods
Strains and maintenance C. elegans strains were maintained using standard procedures (Stiernagle 2005) . Strains used in this study include GE24 [pha-1(e2123ts) III], WY83 [lin-35(n745) I; ubc-18 (ku254) III; kuEx119(lin-35+; sur-5::GFP)], WY119 [lin-35 (n745)I; pha-1(fd1) III; kuEx119], WY477 [ari-1(tm2549) I; pha-1(e2123ts) dpy-18(e499) III], WY165 [pha-1(e2123ts) III; sup-37(e2215) V], GE336 [pha-1(e2123ts) dpy-18(e499) III; sup-37(e2214) V], GE338 [pha-1(e2123ts) dpy-18(e499) III; sup-37(e2216) V], GE339 [pha-1(e2123ts) dpy-18(e499) III; sup-37(t1954) V], GE340 [pha-1(e2123ts) dpy-18(e499) III; sup-37(t1955) V], GE2158 [tDf2/qc1 dpy-19(e1259) glp-1 (q339) III], DR108 [dpy-11(e224) unc-42(e270) V], WY160 [pha-1(e2123ts) backcrossed five times to CB4856], WY170 [pha-1(e2123ts) III; dpy-11(e224) unc-76(e911) V], WY178 [pha-1(e2123ts) III; dpy-11(e224)sup-37(e2215) unc-76 (e911) V], MT14545 [dpy-11(e224) sup-37(e2215) V], WY732 [sup-37(tm1810) V; fdEx175 (sup-37+, sur-5::GFP)], WY733 [sup-37(tm356) V; fdEx174 (sup-37+, sur-5::GFP)], ZW10430 [Psup-37::his-24::mCherry], WY803 [fdEx176 , and WY835 [sup-37(tm1083) ; fdEx176]. sup-37 deletion alleles (tm356, tm481, and tm1083) and pha-1 deletion alleles (tm3569 and tm3671) were obtained from the National BioResource Project (NBRP) Japan and were confirmed by PCR and outcrossed six times prior to any analysis.
Genetic mapping of sup-37
Preliminary mapping placed sup-37 on LGV linkage group (LG) V (Schnabel et al. 1991 ) (data not shown). To further narrow down the sup-37 region, three-point mapping was performed using the balanced strain pha-1(e2123ts); dpy-11 unc-76/sup-37(e2215). Of the progeny, 10/49 Dpy non-Unc and 49/50 Unc non-Dpy acquired the sup-37 mutation. Furthermore, linked three-point mapping using the strain pha-1 (e2123ts); dpy-11 sup-37(e2215) unc-76/+ resulted in 21/29 Dpy non-Unc and 18/32 Unc non-Dpy animals that retained the sup-37 mutation. For SNP mapping, pha-1(e2123ts) hermaphrodites were backcrossed five times into CB4856 Hawaiian males, and the resulting pha-1(e2123ts); CG4856-5· males were crossed to pha-1(e2123ts); dpy-11 sup-37(e2215) unc-76 hermaphrodites, followed by standard SNP mapping procedures (Fay 2006) . By analyzing 400 Dpy non-Unc and Unc non-Dpy recombinants, the sup-37 mutation was narrowed down to an 300-kb region containing 95 genes between the sequencing SNPs F41E6 at position 10,060 and H14N18 at position 3200 (yy49b05.s1@112,-,59 yy44b04. s1@483,-,33).
Transgenic sup-37 rescue experiments
Extrachromosomal arrays containing fosmid WRM0620dH02 (which contains the sup-37 locus) along with the coinjection marker pTG96 (SUR-5::GFP) (Yochem et al. 1998) , were initially generated in N2 strains (fdEx91-94). Males containing these arrays were then crossed to balanced strains containing the larval-lethal sup-37 deletion alleles tm356 and tm1083. In subsequent generations, array-containing tm356 and tm1083 homozygous strains were isolated and found to be completely rescued for larval lethality by the presence of wild-type sup-37. To measure the activity of the sup-37 arrays in suppression assays, N2 males carrying arrays were mated to pha-1 (e2123ts) dpy-18; sup-37(e2216) hermaphrodites at 16°. F 1 cross-progeny that carried the array were isolated and allowed to self-fertilize. Thirty Dpy L4-stage F 2 's containing the sup-37 rescuing array were transferred to 25°, and their progeny were scored for viability. None of the 30 Dpy animals produced viable array-positive progeny, whereas about three-fourths produced viable array-minus Dpy animals. sup-37 rescue experiments were further validated using extrachromosomal arrays containing an 9.5-kb PCR-generated fragment from C01B7.1 (primers: 59-AGATACACGATAA CTTCCACCC-39, 59-GCAATATCTGCTCATACAGTGCC-39) containing the complete sup-37 locus only, as described above.
Genetic analysis of suppression
To test suppression of pha-1(e2123ts) mutants by the nonlethal sup-37(tm481) deletion allele, pha-1(e2123ts); sup-37(tm481) double mutants were generated by crossing pha-1(e2123ts)/+ males to sup-37(tm481) hermaphrodites at 16°. Cross-progeny animals of the genotype pha-1 (e2123ts)/+; sup-37(tm481)/+ were identified by Poisonprimer PCR for the tm481 deletion (Edgley et al. 2002) and PCR followed by Bst1107I digestion for pha-1(e2123); the e2123ts mutation creates a restriction polymorphism and can be assayed by PCR amplification of the mutant region followed by restriction digestion using Bst1107I. F 1 crossprogeny were allowed to self-fertilize at 16°for 24 hr, and F 2 animals of the genotype pha-1(e2123ts); sup-37(tm481) were identified as described above and tested for growth at 25°. Three independent isolates of pha-1(e2123ts); sup-37 (tm481) mutants were tested for suppression at both 20°a nd 25°; none of the isolates produced viable progeny at either temperature and lethal larvae and embryos displayed a Pun phenotype, consistent with a lack of pha-1 suppression by sup-37(tm481).
To test for suppression of the pha-1 null deletion alleles tm3671 and tm3569 by sup-35 and sup-37, homozygous pha-1 strains carrying extrachromosomal arrays containing the pha-1 rescuing plasmid pBX (Granato et al. 1994a) , along with the co-injection marker SUR-5::RFP (Yochem et al. 1998) , were generated. To assay for suppression by sup-35, array-rescued pha-1 deletion mutants were grown on sup-35(RNAi) plates and array-negative (RFP 2 ) progeny were observed in subsequent generations and further genotyped at the pha-1 locus by PCR (Mani and Fay 2009 ). To assay for sup-37 suppression of the pha-1 deletions, double mutants of pha-1 (tm2569 or tm3671) and sup-37 (tm356 or tm1083) were generated and confirmed by PCR. Moreover, for these strains to be viable, they contained both an RFPmarked rescuing array for pha-1 and a GFP-marked rescuing array for sup-37. Suppression of the pha-1 deletions was ascertained by the presence of RFP 2 /GFP 2 larvae that arrest at the L1 stage because of the absence of rescuing sup-37 + activity. In contrast, RFP 2 /GFP + progeny arrested as embryos with characteristic pha-1 defects. Finally, pha-1 deletion mutants harboring the sup-37(e2215) missense allele, failed to segregate RFP 2 progeny that escaped past embryonic arrest, indicating that this allele failed to suppress the pha-1 deletions.
Intragenic complementation tests
Complementation tests among the three deletion alleles of sup-37 (tm356, tm481, and tm1083) were performed as follows. To generate tm356/tm1083 trans-heterozygous animals, wild-type males were mated with tm1083/dpy-11 unc-42 hermaphrodites, and F 1 cross-progeny males were subsequently mated to tm356/dpy-11 unc-42 hermaphrodites. Eighty viable wild-type putative cross-progeny hermaphrodites were examined for the presence of both deletions by poison-primer PCR. If tm356 and tm1083 fail to complement, then none of the viable cross-progeny should be tm356/tm1083. If tm356 and tm1083 can complement one another, then one-seventh of the viable nonDpy Unc cross-progeny hermaphrodites should be tm356/ tm1083. Notably, of the 80 hermaphrodites analyzed, eight were verified to be cross-progeny that were heterozygous for tm1083 but were balanced by the dyp-11 unc-42 chromosome coming from the mother. If tm356 and tm1083 had complemented, we would have expected that on average four of the eight strains would the carry the tm356 deletion chromosome. In contrast, 24 additional verified cross-progeny contained a wild-type allele along with tm356.
Complementation tests of tm481 with tm356 (and tm1083) were performed as follows. Wild-type males were mated with hermaphrodites homozygous for tm481, and cross-progeny F 1 males were mated to tm356/dpy-11 unc-42 hermaphrodites. Forty viable cross-progeny hermaphrodites from each cross were isolated, allowed to produce F 2 's, and subsequently genotyped for the presence of deletions by poison-primer PCR. If tm481 and tm356 fail to complement, then tm481/tm356 segregants (one-fourth of the total) would be nonviable and therefore absent from the adult population. Of the 40 viable cross-progeny analyzed, eight were tm481/ tm356 and gave rise to additional viable tm481/tm356 animals, indicating that these deletion alleles do complement each other for viability. In the case of tm1083, 9/40 viable animals analyzed were tm481/tm1083, which in turn produced viable tm481/tm1083 animals, indicating that these deletions also complement for viability.
To test for complementation of sup-37(tm481) and sup-37(e2215), pha-1(e2123ts) males were crossed with tm481 hermaphrodites at 16°. Cross-progeny F 1 males of genotype pha-1(e2123ts)/+; tm481/+ were subsequently crossed with pha-1(e2123ts); sup-37(e2215) hermaphrodites at 25°. Twenty cross-progeny hermaphrodites were placed on individual plates, allowed to produce progeny, and then genotyped for both pha-1(e2123ts) and tm481. If tm481/ e2215 can suppress pha-1(e2123ts) lethality at 25°, onefourth of the total cross-progeny should be of genotype pha-1(e2123ts); tm481/e2215. Whereas 12/20 cross-progeny animals tested were homozygous for pha-1(e2123ts), none of the 12 animals were tm481/e2215, indicating that tm481 and e2215 complement for suppression. The above test was also repeated by mating pha-1(e2123ts)/+; tm481/+ males into pha-1(e2123ts) dpy-18; sup-37(e2216) hermaphrodites at 25°. Twenty non-Dpy cross-progeny hermaphrodites were picked, allowed to produce F 2 's, and then genotyped for pha-1(e2123ts) and tm481. Whereas 9/20 animals were tm481/e2216, none of the animals tested were homozygous for pha-1(e2123ts), indicating a lack of suppression by tm481/e2216.
Lethal sup-37 deletion alleles were also tested for their ability to suppress the lethal temperature-sensitive phenotype of the pha-1(e2123ts) at the nonpermissive temperature of 25°. As the protocol was very similar for alleles tm356 and tm1083, only one case will be illustrated here. For the suppression analysis, pha-1(e2123ts) males were crossed with tm356/dpy-11 unc-42 hermaphrodites. Crossprogeny males were then mated to pha-1(e2123ts); sup-37 (e2215) hermaphrodites at 25°. Forty viable putative crossprogeny hermaphrodites were picked, allowed to lay embryos for 8 hr at 25°, and then genotyped for pha-1 (e2123ts) and tm356. The e2123ts mutation was monitored as described above, and the tm356 deletion was assayed by poison-primer PCR. If tm356 and e2215 fail to complement for pha-1 suppression, then one-eighth of the viable crossprogeny F 1 's at 25°should be of the genotype pha-1 (e2123ts); e2215/tm356. Of the 40 viable cross-progeny analyzed, 4 were tm356/e2215 and also homozygous for pha-1 (e2213ts), indicating that that e2215 and tm356 do not complement in the pha-1 suppression assay. Similar findings were observed for tm1083; 4/40 viable animals analyzed were tm1083/e2215 and homozygous for pha-1(e2213ts). Furthermore, the viability of tm356/e2215 and tm1083/ e2215 strains indicates that the e2215 allele complements the lethality associated with the tm356 and tm1083 deletions. In separate experiments, sup-37(e2216) yielded similar results to those described above; tm1083/e2216 and tm356/e2216 animals were viable but failed to complement for suppression of pha-1(e2123ts) at 25°.
RNAi
RNAi was carried out using strains from the Geneservice Library following standard feeding protocols (Ahringer 2005) . To identify sup-37, 90 RNAi clones corresponding to genes present within the SNP-mapped region were fed to strain GE24 [pha-1(e2123ts)] at 20°and 25°and scored for suppression of the pha-1 temperature-sensitive lethal phenotype. A single positive RNAi construct corresponding to C01B7.1/ztf-12 was further confirmed by sequencing of the insert.
qRT-PCR
Total RNA from the assayed strains was extracted from bleached embryos using Trizol reagent (Invitrogen). After DNAase I treatment, first-strand cDNA was synthesized using random primers and SuperScript II Reverse Transcriptase (Invitrogen) at 42°for 1 hr. Using purified first strand cDNA, qRT-PCR was performed using the BioRad SYBR Green supermix in a BioRad iCycler with the following reaction conditions: initial denaturation at 95°for 3 min, followed by 40 cycles of denaturation at 95°for 30 sec, and a combined annealing and extension step at 60°for 30 sec. Fold change in the transcript levels was calculated using the DDCt method. All the samples were analyzed in triplicate and data were tested for reproducibility using an independent biological repeat.
Construction of plasmids
sup-37 transcriptional GFP fusion constructs (P sup-37 ::GFP) pDF139/142 were prepared by inserting an 3.0-kb promoter fragment amplified using the primer pairs 59-AAAACTGCAGCCTTCACCACATCATTCATCCACAT-39 and 59-CGCGGATCCGTCTAACTGGTCGGGAGAATTTGA-39 into the Fire vectors pPD95.77 and pPD95.69, respectively. The 3.0-kb fragment includes the first 10 codons of exon 1 along with sequences upstream of C01B7.1 that extend to the adjacent upstream gene (C01B7.3). pPD95.69 differs from pPD95.77 in that the encoded GFP contains a nuclear localization signal. A P sup-35 ::GFP transcriptional fusion was constructed by inserting an 730-bp genomic fragment consisting of the upstream sup-35 promoter-enhancer region into pPD95.69 using the primer pairs 59-GCTCTAGATGA TAGTCGTGTCGGTGGTCGTC-39 and 59-CGCGGATCCACGT GGGCACGCAAAAGTGTGAGC -39. All recombinant clones were verified by sequence analysis.
To create a SUP-37 translational reporter (P sup-37 ::SUP-37:: mCherry), the genomic sup-37 promoter region (1140-bp upstream sequence) was amplified using the following primers: 59-AAAAAACTGCAGCATCTCGCTTTCCGATCGCG-39 and 59-CCCCCCTCTAGACAGGTGATCTGGAAAACATAGTTG-39. This PCR product was cloned into PstI and XbaI sites of plasmid L3691 (Fire Lab Vector kit) and verified by sequencing to generate plasmid pDF146. To create the cDNA clone containing the complete sup-37 isoform A sequence, we first inserted 1003 bp from the sup-37 cDNA clone YK817.g3 into the host plasmid containing sup-37 clone YK1129.g7. Full-length sup-37 cDNA was then PCR amplified from the resulting cDNA clone using the following primers: 59-AAA AAAGGCGCGCCATGAGCATCAGCGGAGAGGACAAC-39 and 59-CCCCCAGGTACCGGATCAGAAGAGACACCATCATCATC TTCTTCCATC-39. This product was cloned in frame with GFP into plasmid pDF146 using sites for AscI and KpnI, thus placing the cDNA encoding SUP-37::GFP 24 nucleotides downstream from the inserted sup-37 promoter. To create an mCherry version of the SUP-37 fusion reporter (pDF148), GFP sequences were excised from pDF147 using KpnI and NheI restriction enzymes and replaced with an mCherry sequence amplified from pJA304 using the following primers: 59-AAAAAGGTACCGGGAGGTGGAGGTGGAGCTATGG TCTCA-39 and 59-AAAAAGCTAGCTTACTTATACAATTCAT CCATGCCACCTGTCGAGTGCCG -39. The mCherry amplicon also contained a 59-spacer sequence encoding five glycines and an alanine to facilitate folding and function of the fusion protein. The sup-37 cDNA, GFP, and mCherry sequences were further verified by sequencing.
To generate the P myo-2 ::SUP-37 construct, sup-37 cDNA was PCR amplified from the cDNA clone YK1129.g7 using the following primers: 59-CCAAAAGCTAGCATGAGCATCAG CGGAGAGGACAAC-39 and 59-GGGCGCGGTACCTTAATCAGA AGA GACACCATCATCATCTTCTTCCATC-39. This PCR amplicon was cloned into NheI and KpnI sites of L2531 plasmid (Fire Lab Vector kit) and verified by sequencing.
Feeding assays and pharyngeal pumping
For bead internalization assays, NGM plates were seeded with a mixture of 20 ml of fluorescent beads (Fluoresbrite 0.5-mm Polychromatic Red Microspheres from Polysciences) in 1 ml of overnight cultures of OP50. The plates were incubated at 20°, and bead ingestion by L1 larvae was monitored by DIC/fluorescence microscopy. NGM plates seeded with OP50 that expresses GFP (Labrousse et al. 2000) were prepared in a similar way as regular OP50-NGM plates, and fluorescence was monitored by DIC/fluorescence microscopy.
To assess pharyngeal pumping, WY733 adults (genotype sup-37(tm356)V; fdEx174 [sup-37(+); pTG96(sur-5::gfp)]) were allowed to lay eggs overnight under standard conditions. The next day, a glass cover was gently placed over the middle part of the bacterial lawn, followed by time-lapse microscopy of L1's with a ·40 objective, a Nikon Eclipse E600 microscope, a CoolSnap digital camera, and OpenLab software. Intervals of 30 sec were recorded at ambient temperature (25°). Six sup-37 mutant homozygotes were distinguished from two sup-37(+) siblings by the absence of the fdEx174 array that expresses GFP and rescues sup-37 (tm356). Pumping behavior and rates were determined following playback of the recordings at low speeds. Pumping was also grossly examined with a dissecting microscope capable of fluorescence and ·110 magnification.
Genetic mosaic analysis
Healthy L4 or young adult segregants from the WY733 strain were examined with a dissecting microscope equipped for fluorescence for mosaic patterns of nuclear green fluorescence (Yochem et al. 1998) , conferred by pTG96, indicating mitotic nondisjunction of the fdEx174 extrachromosomal array that also contains sup-37(+) DNA. The mosaics were then examined with a compound microscope, and the embryonic cell that must have lost the array during development of a particular mosaic animal was deduced from the anatomical pattern of fluorescence on the basis of the nearly invariant cell lineage of C. elegans (Sulston et al. 1983) .
Although they can be more difficult to interpret, a small number of mutant mosaics were also analyzed. WY733 adults were removed from plates after laying eggs overnight, thereby producing progeny that had hatched within a narrow timeframe. Two days later, these plates, which contain a partially synchronous population of healthy worms, were examined for arrested L1's that also exhibited GFP, indicating nonrescued mosaics that had nevertheless inherited the array. These plates also were a source of some of the healthy mosaics and allowed an assessment of whether or not certain classes of mosaics, although rescued for early requirements of sup-37, had other disadvantages in growth or development.
Microscopy of pha-1 and sup-37 expression
Fluorescence microscopy was performed using a Nikon Eclipse microscope. Quantification of the GFP and mCherry fluorescence in embryos was carried out using Open Lab software version 5.0.2. All images were captured using identical exposure times, and all embryos used in our analysis were of similar developmental stages (200-300 cells). An average of the mean fluorescence was calculated to compare expression levels. P-values were determined using a two-tailed Student's t-test.
Results

Molecular identification of sup-37
Recessive mutations in sup-37 can suppress hypomorphic alleles of pha-1 (Schnabel et al. 1991) as well as the synthetic lethal phenotypes of lin-35; ubc-18, lin-35; pha-1, ubc-18; pha-1, and pha-1; ari-1(RNAi) double mutants (Fay et al. 2004; Qiu and Fay 2006) . To better understand the role of sup-37 in pharyngeal development and genetic suppression, we molecularly identified the sup-37 locus. We initially verified the location of sup-37 on LGV (Schnabel et al. 1991) and then further refined the position of sup-37 using genetic and SNP mapping methods. These approaches narrowed the sup-37 locus to an 300-kb region containing 95 predicted genes. To identify sup-37, 90 RNAi-feeding clones corresponding to this region were tested for suppression of pha-1(e2123ts) temperature-sensitive lethality at 20°a nd 25°. A single RNAi clone that targeted gene C01B7.1/ ztf-12 showed strong suppression of pha-1(e2123ts) at the nonpermissive temperature of 25°and also at the semipermissive temperature of 20°, suggesting that C01B7.1 defines the sup-37 locus ( Figure 1 ; Table 1 ; data not shown). In addition, RNAi of C01B7.1 suppressed the synthetic lethal phenotypes of lin-35; ubc-18, lin-35; pha-1, and ari-1; pha-1 double mutants (Table 1) , consistent with our previous observations.
To obtain further evidence that C01B7.1 defines sup-37, we carried out transgenic rescue experiments (also see below). Extrachromosomal arrays containing wild-type copies of C01B7.1 efficiently reverted the viability of pha-1 (e2123ts); sup-37(e2216) mutants at 25°, such that animals containing GFP-marked C01B7.1 arrays arrested as embryos or larvae and displayed pharyngeal morphogenesis defects characteristic of pha-1(e2123ts) single mutants (see Materials and Methods). Additionally, we sequenced the genomic region encompassing C01B7.1 in six independently isolated alleles of sup-37 (Schnabel et al. 1991) . Three of the sup-37 alleles (e2214, e2215, and t1955) showed an identical G-to-A transition in exon 3, leading to a change from aspartic acid to asparagine at amino acid (aa) position 479 ( Figure 2 ; Table 2 ; Supporting Information, Figure S1 ). Two other alleles of sup-37 (e2216 and t1070) contained an identical C-to-T transition in exon 3, leading to a change from serine to leucine at aa position 481 ( Figure 2 ; Table 2 ; Figure S1 ). The final allele of sup-37 (t1954) contained a G-to-A transition in exon 3 leading to a substitution of a serine for glutamate at aa position 462 ( Figure 2 ; Table 2; Figure S1 ). These results, together with findings from transgenic rescue and RNAi phenocopy studies, demonstrate that sup-37 corresponds to C01B7.1/ztf-12.
sup-37 encodes a predicted Zn-finger protein WormBase predicts three different isoforms of C01B7.1 (a-c). The two long isoforms (C01B7.1a and C01B7.1c) contain eight exons, which differ only in their fourth exon ( Figure  2 ; Figure S2 ). The shorter isoform (C01B7.1b) is composed of only four exons; these correspond to the first four exons of the C01B7.1c isoform, but the C01B7.1b isoform also includes additional 39 sequences (Figure 2 ; Figure S2 ). To confirm these predictions, we sequenced available EST clones (NBP Japan) corresponding to the C01B7.1 locus. Sequencing validated the existence of isoforms a-c and identified an additional long isoform (C01B7.1d; clone yk817g03) that is most similar to C01B7.1c but is missing the fifth exon, which is common to C01B7.1a and C01B7.1c ( Figure 2 ; Figure S2 ). These predictions are further supported by available RNA sequencing data (WormBase) and by homology comparisons with other nematode species ( Figure S3 ).
InterproScan predicts seven C2H2-like Zn-finger motifs at aa positions 93-116, 122-145, 413-434, 444-469, 592-615, 795-815, and 822-845 in isoforms CO1B7.1a and CO1B7.1c; the CO1B7.1d isoform contains the same Zn fingers with the three C-terminal fingers located at aa positions 570-593, 773-793, and 800-823. The CO1B7.1b isoform contains only the first four Zn fingers in common with the other isoforms. Whereas Zn fingers 1, 3, and 6 are 100% conserved in putative orthologs of ztf-12 in C. remanaei and C. briggsae, the other Zn fingers show slight variations ( Figure S3 ). All the identified sup-37 missense mutations are contained within the common fourth exon of all the sup-37 isoforms and occur either within or just downstream of the fourth Zn finger (Figure 2 ; Figure S1 ).
In addition, the identified missense mutations alter aa residues that are completely conserved in SUP-37 homologs from C. remanaei and C. briggsae ( Figure S3 ).
sup-37 is an essential gene
In addition to the point mutations described above, sequence analysis confirmed three sup-37 deletion alleles generated by the Japanese knockout consortium. tm1083 is an in-frame insertion-deletion mutation that removes 237 aa of SUP-37 from positions 87-323 and inserts a single aa at position 87 ( Figure 2 ; Figure S2 ). tm356 is a 576-bp deletion leading to a frameshift and premature stop codon following position 501 (Figure 2 ; Figure S2 ). Both tm1083 and tm356 are predicted to affect all isoforms of sup-37 and are likely to comprise molecular nulls ( Figure 2 ). The region deleted in tm1083 removes the first two Zn fingers, whereas the regions deleted by tm356 do not affect any of the Zn fingers. Interestingly, tm356 and tm1083 homozygous mutants are not viable and undergo early larval arrest, indicating that sup-37 is an essential gene (also see below). Consistent with this, transgenic arrays expressing wild-type sup-37 are sufficient to fully rescue the lethality of tm356 and tm1083 homozygous mutants. tm481 is a 509-bp deletion that affects only the b-d isoforms of sup-37 and does not affect the N-terminal Zn fingers (Figure 2 ). In contrast to tm1083 and tm356, tm481 homozygous mutants are viable, indicating that sup-37 splice variants containing the exon deleted by tm481 (CO1B7.1b-d) do not perform essential functions (Table 2 ). DIC images of pha-1(e2123ts) (left) and pha-1(e2123ts); sup-37(RNAi) (right) embryos at 25°. Black and white arrowheads indicate anterior and posterior pharyngeal boundaries, respectively. The abnormal pharynx in the pha-1(e2123ts) mutant is also outlined. e, embryo. Bar for both left and right, 10 mm.
Table 1 Suppression of pharyngeal defects by sup-37
Genotype
Fertile adults (%) vector RNAi (20°) 2.4 (n = 187) lin-35; ubc-18; C01B7.1 RNAi (20°) 66.4 (n = 164) lin-35; pha-1(fd1) (20°) 0 ( n = 248) lin-35; pha-1(fd1); vector RNAi (20°) 3.1 (n = 143) lin-35; pha-1(fd1); C01B7.1 RNAi (20°) 74.6 (n = 151) ari-1(tm2549); pha-1(e2123) (16°) 1.5 (n = 338) ari-1(tm2549); pha-1(e2123); vector RNAi (16°) 1.7 (n = 192) ari-1(tm2549); pha-1(e2123); C01B7. 
Functional analysis of sup-37 alleles
To characterize the activities of the identified sup-37 alleles, we carried out genetic complementation tests (Table 3 ; also see Materials and Methods). In contrast to all other combinations assayed, tm356/tm1083 trans-heterozygous mutants were not viable, further demonstrating that sup-37 is an essential gene. Combinations of the tm356 or tm1083 deletion with sup-37 missense alleles were uniformly viable. This result, together with sup-37(RNAi) findings ( Figure 1 ; Table 1 ), indicates that the sup-37 missense alleles are hypomorphic. In addition, pha-1(e2123ts) mutants that were trans-heterozygous for either of the two null sup-37 deletions (tm356 or tm1083) and two of the tested missense alleles (e2215 and e2216) were fully suppressed at 25° (Table 3 ). In contrast, tm481 homozygous mutants did not suppress pha-1(e2123ts) mutants, and tm481 complemented all other tested sup-37 alleles in both viability and pha-1 suppression assays. Thus, isoforms containing the exon deleted by tm481 (b-d) do not appear to have appreciable roles in either viability or pharyngeal morphogenesis. We further note that growth of homozygous tm481 mutants at 25°leads to a high incidence of sterility and that these sterile animals are defective at oogenesis (data not shown). However, several pieces of evidence indicate that this temperature-sensitive sterility may not result specifically from a reduction in sup-37 activity. (1) The sterile phenotype of tm481 is complemented in trans by both tm356 and tm1083 null deletion mutations (Table 3) . (2) tm481 sterility is not rescued by sup-37(+)-containing extrachromosomal arrays that rescue other sup-37-associated phenotypes (data not shown). (3) sup-37(RNAi) at 25°does not result in high levels of sterility in N2 animals (data not shown). Thus, the sterility associated with tm481 may be due to a closely linked mutation that was not separated from the sup-37 locus following outcrossing.
SUP-37 is required for normal pharyngeal pumping
The sup-37 null deletion alleles tm356 and tm1083 exhibited a fully penetrant L1 larval arrest when homozygous. Furthermore, homozygous tm356 and tm1083 mutants displayed no morphological abnormalities indicative of developmental defects. Also, the mutants can move normally and exhibit foraging behavior. These observations, together with our observation that sup-37 is expressed strongly in the larval pharynx (see below), suggested that sup-37 null mutants may have defective pharynges that preclude proper feeding. Consistent with a feeding defect, the intestines of the mutants have refractile vacuoles indicative of starvation (Schroeder et al. 2007 ). To test this, homozygous tm356 and tm1083 mutants were fed fluorescent Escherichia coli (OP50) and analyzed by compound microscopy. In contrast to wild-type L1 larvae, which uniformly contained intact fluorescent OP50 from the anterior pharyngeal lumen up to the posterior pharyngeal bulb (n = 75), 100% (n = 75) of sup-37 null mutants contained fluorescent OP50 up to the anterior bulb only (Figure 3 , A-D). In addition, 100% (n = 75) of tm356 and tm1083 homozygous mutants failed to internalize fluorescent beads past the grinder, whereas wild-type animals uniformly contained beads throughout the entire pharyngeal-intestinal tract ( Figure 3 , E-H and data not shown; n = 75).
To understand the feeding defect in more detail, pharyngeal pumping of six sup-37(tm356) homozygotes was compared with that of two nonmutants by time-lapse video microscopy. The rate of pumping for the two nonmutants was 195 and 192 pumps per minute, both of which are similar to the wild-type rate of 240 pumps per minute at room temperature (Altun et al. 2002 (Altun et al. -2010 . In contrast, five of the six mutants, when they did pump, exhibited the much lower rates of 36, 58, 53, 60, and 30 pumps per minute. The sixth mutant failed to pump all together. Moreover, pumping by the mutants was invariably less robust than that of the wild-type animals: contractions of the corpus, the anterior half of the pharynx, were not seen, and the contractions of the terminal bulb appeared weak and sometimes sporadic. The contractions of the terminal bulb, although insufficient for thriving, may nevertheless be sufficient for the ingestion of the small amounts of fluorescent bacteria and beads present in the mutants (Figure 3 ).
The focus of sup-37 activity for proper feeding may be the pharynx As noted above, sup-37 homozygous null mutants are starved and invariably arrest growth and development in the first larval stage. Their impaired pharyngeal pumping implies a defect in the function of pharyngeal muscle cells, as pharyngeal neurons are largely dispensable for pumping (Avery and Horvitz 1989) . To investigate this notion in more detail, healthy genetic mosaics that segregated from WY733 were analyzed. Because these mosaics were healthy and had reached the L4 or young adult stage, it is reasonable to assume that wild-type sup-37 present on the fdEx174 array functioned in these mosaics in the proper part of the cell lineage required for normal pharyngeal pumping.
The only early cells of the lineage that did not undergo losses of the array were P 1 ; EMS, one of the daughters of P 1 ; and MS, a granddaughter of P 1 , indicating that the focus of gene activity descends from MS. A few mutant mosaic-GFP (+) L1s that were arrested with a starved appearance were also examined, although caution is required in interpreting them, as developmental arrest could result from effects other than a lack of wild-type sup-37 gene activity. They could, for example, have been sick for unknown reasonsperhaps from overexpression of the array in certain parts of the cell lineage, following the increase in copy number that results from nondisjunction. Nevertheless, there were seven arrested mosaics that could be easily characterized. Two had a loss in P 1 , three had a loss in EMS, and two had a loss in MS. Another arrested L1 had suffered losses of the array in ABa, MS, and P 2 . These mosaics are therefore the reciprocal of the healthy mosaics, none of which had a loss in P 1 , EMS, or MS (Figure 4 ). Other mosaics that were arrested as starved L1's had more limited inheritance of the array.
Both approaches implicated one or more descendants of MS as the focus of sup-37 gene activity. A paradox, however, was the isolation of one MSa and three MSp losses. That is, MSa can compensate for a loss in its sister, MSp, and vice versa. An interpretation of this variability is that the focus of gene activity is composed of redundant cells, some of which descend from MSa and some from MSp. Another interpretation is that the focus is multinucleated, with some nuclei in the syncytium descending from MSa and some from MSp. Inheritance of sup-37(+) from either progenitor would then be sufficient for rescue.
Although a single cellular focus could not be pinpointed, the mutant phenotype, the mosaic analysis, and the structure of the pharynx together raise the possibility that the focus is a gestalt composed of the three pm3 and the three pm4 muscles of the pharynx. These muscles are responsible for contraction of the corpus (Altun et al. 2002 (Altun et al. -2010 , a contraction not seen in sup-37(tm356) homozygotes. The pm1 and pm2 muscles are also involved in contraction of the corpus, but these descend solely from ABa and therefore cannot be critical foci of sup-37. One reason for the inability to pinpoint the focus might be the lineal complexity of these muscles, because each of them is dinucleate, as follows: pm3 dorsal, one nucleus from MSa and the other from MSp; pm3 left subventral, both nuclei from ABa; pm3 right subventral, both nuclei from ABa; pm4 dorsal, one nucleus from MSa and the other from MSp; pm4 left subventral, both nuclei from MSa; pm4 right subventral, one nucleus from ABa, the other from MSp (Albertson and Thomson 1976; Sulston et al. 1983 ). An MSp loss would therefore leave all six muscles sup-37(+). An MSa loss would render the pm4 left subventral muscle genotypically sup-37(-), but the remaining five muscles would be sup-37(+), which might be sufficient for pumping. The ABa(+) MS(2) mosaics are problematic, because the pm4 right subventral muscle, which has a nucleus that descends from ABa, should be positive for the array. Perhaps one positive muscle is not sufficient for adequate contraction of the metacorpus, which is mediated by the pm4 muscles. In an ABa(2) MS(+) mosaic, all three pm4 muscles are plus, but only one pm3 
Let, lethal; V, viable; S, suppression; NS, no suppression. Suppression was scored in a pha-1(e2123ts) homozygous background at 25°. Note that suppression was not scored for all possible genotype combinations. In the case of tm356/tm481 and tm1083/tm481 34/50 and 18/25 hermaphrodites were fertile at 25°, respectively.
muscle is plus. Perhaps the pm4 muscles of the metacorpus provide most of the contractile force of the corpus. Several of the arrested mutant mosaics provided evidence in support of this interpretation of the focus and raised the possibility that robust contraction of the corpus requires that both the pm3 muscles and the pm4 muscles be functional. In six of the mutant mosaics, all three of the pm4 muscles were minus for the sup-37(+) array, but some or all of the pm3 muscles were plus. Conversely, all three of the pm3 muscles were minus and all three of the pm4 muscles plus in two of the mutant mosaics. Thus, the specific requirement for sup-37 in the pharynx is apparently somewhat flexible, but is required within one of at least several combinations of pm3 and pm4 muscle cells. We also note that we attempted to rescue the pumping defect of sup-37 null mutants using a P myo-2 ::SUP-37 reporter, which should express SUP-37 specifically in pharyngeal muscles. This construct, however, proved to be highly toxic, suggesting that overexpression of SUP-37 may be deleterious to pharyngeal muscle function or development.
The mosaic analysis indicates other functions for sup-37 E(-) mosaics, those lacking the sup-37(+) array in all cells of the intestine, were easy to identify (Figure 4 ). These mosaics Figure 4 Summary of the mitotic losses in healthy sup-37 (tm356) genetic mosaics. On the basis of anatomical studies, the number of healthy animals that had negative clones-likely a consequence of nondisjunction-is shown next to the early embryonic cell that failed to inherit the sup-37(+) sur-5::GFP array (fdEx174) following mitotic division. One of the ABa losses is shown in parentheses, because the animal, although rescued for the sup-37 feeding defect, was not as healthy as the other animals that had had an AB or ABa loss. Those cells that contribute descendants to the pharynx or to the intestine are shown. Blastomeres that did not give rise to negative clones are shown in green, as is their lineal relationship. Figure 3 Bacteria and fluorescent bead ingestion by wild type and sup-37 mutants. GFP-expressing OP50 Escherichia coli were fed to wild-type N2 (A and B) and sup-37 (tm356) mutants (C and D). (A and C) GFP-DIC overlays. a, anterior; p, posterior pharyngeal bulbs, respectively. Note that bacteria are present within the pharyngeal lumen of N2 animals from the anterior buccal cavity to the posterior bulb, where they are mechanically processed leading to loss of fluorescence in more posterior portions of the pharynx and intestinal tract (A and B) . In contrast, sup-37 mutants are unable to ingest bacteria beyond the anterior bulb (C and D). Fluorescent bead ingestion in wild type (E and F) and sup-37(tm356) mutants (G and H). E and G show fluorescent-DIC overlays. i, intestine. N2 animals contain beads in the lumen of the pharynx and throughout the intestine (E and F), whereas sup-37 mutants do not contain beads past the posterior bulb (G and H). Bars, 10 mm in A (A-F); 10 mm in G (G and H).
were invariably slightly retarded in growth relative to nonmosaics on partially synchronous plates (L4s vs. adults). One half of them had a scrawny appearance; the remaining resembled normal worms. Thus, there may be a non-essential requirement for sup-37 in the intestine, but this possibility has not been examined in detail. In addition, there appears to be a requirement for sup-37 in the somatic gonad for proper ovulation, depending on which gonadal arm is plus or minus for the array. When an arm was negative for sup-37, the oocytes of that arm were abnormally small and were not in single file ( Figure 5, C and D) . Positive arms, on the other hand, have oocytes of normal appearance ( Figure  5, A and B) . The defect in the mutant arm appears to result from abnormally slow movement of oocytes into the spermatheca, a process that normally requires dilation of the distal part of the spermatheca and contractions of proximal sheath cells (Altun et al. 2002 (Altun et al. -2010 Greenstein 2005) . In addition, on the basis of gross nuclear morphology, these oocytes appear to be endomitotic. The sup-37 gene is not absolutely required for this process, as some oocytes can transit the spermatheca, and mosaics completely minus for the somatic gonad produce some progeny, which often exit the vulva as hatchlings. Whether the focus of gene activity is the spermatheca, the sheath cells, or both is not known.
Expression of sup-37
To determine the expression pattern of sup-37 during development, we first generated extrachromosomal arrays expressing P sup-37 ::GFP promoter fusions containing 3.0 kb of sup-37 upstream sequences. In addition, we made use of a strain containing an integrated P sup-37 ::his-24::mCherry reporter containing 1 kb of sup-37 upstream sequences (Liu et al. 2009 ). All tested strains showed strong enrichment of reporter expression within the pharynx beginning at the 500-cell stage of embryogenesis and continuing throughout larval development and adulthood ( Figure 6, A-H) . In addition, weak-to-modest levels of sup-37 reporter expression were observed in all other cell types ( Figure 6 ; data not shown). Expression of sup-37 reporters in pharyngeal muscle is consistent with an autonomous role for SUP-37 in pharyngeal pumping. In addition, sup-37 is temporally and spatially coexpressed with both sup-35 and pha-1 and shows a similar degree of enrichment in the pharynx as was observed for SUP-35::GFP (Fay et al. 2004; Mani and Fay 2009) .
We also examined expression of full-length (isoform-a) SUP-37::GFP and SUP-37::mCherry fusion proteins. Both reporters localize predominantly to nuclei during late stages of embryogenesis (Figure 7 , A and B; data not shown), consistent with a role for SUP-37 in the nucleus. Expression of these constructs was, however, relatively dim and quite variable as compared with the sup-37 transcriptional reporters. Expression of the SUP-37 translational reporters was also occasionally detected in both the cytoplasm and nuclei of early-stage embryos at time points preceding morphogenesis (data not shown). In larval and adult stages, SUP-37:: mCherry was expressed in the pharyngeal muscle groups pm3, pm4, and pm6, but not consistently in other cells of the pharynx (Figure 7 , C and D). This result is strikingly consistent with our mosaic analysis indicating an essential function for SUP-37 in a subset of the pm3 and pm4 muscle groups. In addition, SUP-37::mCherry expression was faint but detectable in the spermatheca of adult hermaphrodites (data not shown). This observation is consistent with findings from the mosaic analysis demonstrating a requirement for sup-37 in the somatic gonad to promote ovulation. Expression of SUP-37::mCherry was not detected in the somatic gonad sheath cells, which also play a role in ovulation. Although this might suggest a specific role for sup-37 in the spermatheca, we observed several cases where at least some cells within the spermatheca of sup-37(tm1083) mutants were positive for SUP-37::mCherry expression, but these gonads were nevertheless defective at ovulation. Thus, SUP-37 might be required in sheath cells but is expressed at levels below our limits of detection. Alternatively, failure of SUP-37::mCherry to consistently rescue ovulation defects could be due to mosacism of array within the spermathecal cells of affected animals or may be due to reduced activity of the fusion protein.
At present, it is unclear why the SUP-37 translational fusion reporters, which contain the same upstream regulatory sequences as that of the transcriptional reporters, differ from the transcriptional reporters in their pattern and intensity of expression. It is possible that the fusion proteins are unstable or targeted for degradation or that additional regulatory elements exist within the coding sequence of sup-37. In tests for biological activity, SUP-37::mCherry was found to rescue the embryonic lethality of sup-37 (tm1083) null mutants, indicating that the fusion protein is biologically active. In summary, clear nuclear expression of the translational reporters is consistent with a role for SUP-37 in transcriptional regulation and places SUP-37 in the same cellular compartment as SUP-35 during latter stages of embryogenesis.
SUP-37 expression is not regulated by the LIN-35 or UBC-18-ARI-1 pathways
We sought to determine whether sup-37 expression is regulated by the LIN-35 or UBC-18-ARI-1 networks as was observed for sup-35 (Mani and Fay 2009 ). In contrast to P sup-35 ::GFP, P sup-37 ::GFP expression did not change significantly in lin-35(RNAi)-treated embryos (Figure 8 , G and H). We also did not detect a consistent increase in endogenous sup-37 mRNA levels in lin-35(n745) mutants using qRT-PCR ( Figure 8A ). sup-35 is positively regulated by HCF-1, which antagonizes LIN-35 activity and functions as a putative positive regulator of E2F target-gene transcription (Mani and Fay 2009 ). Whereas embryos containing P sup-35 ::GFP showed a significant decrease in GFP expression following hcf-1(RNAi), embryos containing a P sup-37 ::GFP were unaffected by this treatment (Figure 8 , C-H). Furthermore, sup-37 mRNA levels, as well as P sup-37 ::GFP and P sup-37 ::his-24::mCherry reporters, were not sensitive to inhibition of ubc-18 or ari-1 activity, indicating that UBC-18-ARI-1 does not regulate sup-37 at the level of transcription (Figure 8 , A and G; data not shown). Finally, in contrast to SUP-35::GFP, a SUP-37:: mCherry fusion reporter was not affected by RNAi of either ubc-18 or ari-1, indicating that UBC-18-ARI-1 does not regulate sup-37 at the level of protein stability (Figure 8 , I and J). Taken together, these results indicate that, unlike SUP-35, SUP-37 expression is not regulated by either the LIN-35 or UBC-18-ARI-1 pathways.
SUP-37 and SUP-35 may act in a common step to repress PHA-1 expression
We previously reported that SUP-35 can inhibit the expression of pha-1, thereby providing an explanation for the suppression of hypomorphic alleles of pha-1 by sup-35 mutations (Mani and Fay 2009) . Consistent with this, we found that mutations in sup-37 led to a significant increase in the abundance of pha-1 mRNA on the basis of both transcriptional and translational pha-1 GFP reporters, although these effects were somewhat weaker than those observed for sup-35 (Figure 9 ) (Mani and Fay 2009 ). The observed increase in P pha-1 ::GFP fluorescence in sup-37 mutant embryos indicates that repression of pha-1 by SUP-35 and SUP-37 occurs at the level of transcription (Figure 9 , A-C and G) (Mani and Fay 2009 ). In addition, sup-37(RNAi) embryos had slightly increased levels of a functional PHA-1::GFP translational fusion, suggesting that the increase in pha-1 mRNA levels in sup-37 mutants leads to a corresponding increase in PHA-1 protein levels (Figure 9, D-F and H). As previously described, SUP-35 overexpression leads to embryonic and larval arrest that phenocopies pha-1 LOF mutations (Mani and Fay 2009 ). Furthermore, arrest induced by SUP-35 overexpression is completely dependent on the presence of wild-type SUP-37, suggesting that SUP-37 may act downstream of SUP-35 to mediate pha-1 transcriptional repression. Alternatively, SUP-37 could serve as an upstream activator of SUP-35 or may act in a pathway that is parallel to SUP-35. Finally, SUP-37 could act at the same level as SUP-35, possibly within a single complex. Several findings indicate that SUP-35 and SUP-37 may act at a common step. First, sup-35; sup-37 double mutants did not show enhanced expression of pha-1 relative to single mutants, suggesting that SUP-35 and SUP-37 are unlikely to act in either parallel or partially redundant pathways ( Figure 8G ). Second, sup-37 mRNA levels were unaffected by sup-35 mutations, indicating that sup-37 is not a downstream transcriptional target of SUP-35 ( Figure 8A ). Consistent with this, expression of a full-length SUP-37::mCherry fusion protein was not affected following sup-35(RNAi) (data not shown). Finally, SUP-35 mRNA levels were not affected by loss of sup-37, indicating that sup-35 is not a transcriptional target of SUP-37 ( Figure 8B ). Our collective data suggest that SUP-37 and SUP-35 may act at the same step within a single pathway or complex to regulate PHA-1 expression and pharyngeal development.
Negative regulation of PHA-1 expression is not the primary mechanism of pha-1 suppression by sup-35 and sup-37 mutations Studies using a large chromosomal deficiency, tDf2, which deletes both sup-35 and pha-1, as well as 46-72 additional genes, suggested that loss of sup-35 function could not suppress a complete loss of pha-1 activity (Schnabel et al. 1991; Mani and Fay 2009 ). We sought to confirm these results using two deletion alleles of pha-1, tm3671 and tm3569, which have been extensively backcrossed and can be maintained as homozygous stocks through the use of a pha-1-rescuing RFP-marked extrachromosomal array. Both pha-1 deletion strains exhibit 100% lethality of self-progeny that fail to inherit the rescuing array, and these lethal embryos resemble pha-1(e2123ts) mutants at 25°. pha-1(tm3671) contains a 203-bp deletion that removes part of the second exon of pha-1 and creates a premature stop codon, whereas pha-1(tm3569) contains an in-frame 568-bp deletion from exons 2-4, removing 149 amino acids of PHA-1. On the basis of the nature of these lesions as well as the phenotype of the mutant embryos, both deletions are presumed to be null alleles.
A summary of our findings on the suppression of the pha-1 deletions can be found in Table 4 . Surprisingly, we observed that sup-35(RNAi) can suppress the lethality of both pha-1(tm3569) and pha-1(tm3671), such that both deletion mutations could be propagated as homozygotes when grown continuously on sup-35(RNAi); subsequent removal to control RNAi plates led to lethality of the pha-1 deletion strains within two generations. Furthermore, pha-1 deletion strains placed on pha-1(RNAi) sup-35(RNAi) double-RNAi plates were also suppressed, indicating that any residual activity of the pha-1 deletions was unlikely to account for the ability of sup-35(RNAi) to achieve suppression. To determine whether sup-37 mutations could also suppress pha-1 null mutants, we tested one missense allele (e2215) and the two larval-lethal deletion alleles (tm356 and tm1083) of sup-37. In the case of the sup-37 deletions, additional methods were used to maintain strains carrying two separate lethal mutations (see Materials and Methods). Whereas the hypomorphic sup-37(e2215) allele failed to suppress pha-1 null embryonic lethality, both null alleles of sup-37 suppressed the embryonic lethality and morphogenesis defects of the pha-1 deletions. In this case, suppressed animals arrested as wild-type-looking L1 larvae due to the absence of sup-37 activity. Additionally, RNAi of pha-1 did not disrupt the ability of the sup-37 null mutants to suppress the pha-1 deletions. Failure of the sup-37 missense allele to suppress the pha-1 null deletions indicates that the strength of sup-37 loss-of-function mutations and their corresponding ability to suppress pha-1 loss-of-function alleles is correlated. This is also consistent with the relatively modest effects on PHA-1 expression observed in the sup-37 hypomorphic mutant background vs. the sup-35 null deletion ( Figure 9 ). Taken together, our findings indicate that, although SUP-35 and SUP-37 can negatively regulate pha-1 expression, pha-1 transcriptional derepression cannot account for the ability of sup-35 and sup-37 mutations to suppress pha-1 loss of function. This conclusion is further supported by our finding that treatment conditions in which sup-35(RNAi) leads to only a modest increase in the expression of the P pha-1 ::GFP reporter (1.2-fold), nevertheless still efficiently allow suppression of pha-1(e2123ts) lethality at 25°(data not shown). Furthermore, we find that the discrepancy between the ability of sup-35(RNAi) to suppress pha-1 null mutations and the inability of deleted sup-35 to suppress homozygous tDf2 embryos can be explained by the presence of maternal sup-35 in the progeny of the balanced tDf2/+ strain. Specifically, whereas tDf2/+ heterozygotes placed on vector-control RNAi segregate 24.3% lethal pha-1-like embryos and 0.1% arrested larvae (n = 572), tDf2/+ placed on sup-35(RNAi) segregate 2.7% lethal embryos and 20.5% arrested L1 larvae (n = 526). These results demonstrate that depletion of maternal sup-35 is sufficient to bypass the pha-1-like embryonic arrest phenotype of tDf2/tDf2 No pha-1(tm3569); sup-37(tm356) Yes pha-1(tm3569); sup-37(tm356); pha-1(RNAi) Yes pha-1(tm3569); sup-37(tm1083) Yes pha-1(tm3569); sup-37(tm1083); pha-1(RNAi) Yes pha-1(tm3671); sup-37(e2215) No pha-1(tm3671); sup-37(tm356) Yes pha-1(tm3671); sup-37(tm356); pha-1(RNAi) Yes pha-1(tm3671); sup-37(tm1083) Yes pha-1(tm3671); sup-37(tm1083); pha-1(RNAi) Yes
All experiments were carried out at 20°. Yes, suppression of pha-1 embryonic and larval defects was observed in animals of that genotype. Suppressed worms do not display pha-1-associated defects but arrest at the L1 stage due to the absence of sup-37 function. homozygotes. The presence of arrested tDf2/tDf2 larvae, which do not display pharyngeal defects, is presumably due to the zygotic absence of one or more additional genes within the tDf2 region. Our finding that maternal sup-35 is sufficient to preclude suppression of pha-1 null mutants is also consistent with previous results showing that sup-35 has a maternal component (Schnabel et al. 1991; Mani and Fay 2009 ). However, whereas loss of maternal or zygotic sup-35 can suppress pha-1 hypomorphic mutations (Schnabel et al. 1991) , loss of both maternal and zygotic sup-35 is apparently required for suppression of pha-1 nulls. In summary, we conclude that loss of sup-35 or sup-37 activity can efficiently suppress the null phenotype of pha-1 and that transcriptional derepression of pha-1 in sup-35 and sup-37 mutants must therefore play a minor role at most in the observed genetic suppression.
Discussion
On the basis of our findings described above, we propose the following working model (Figure 10 ). PHA-1 promotes pharyngeal development and embryonic morphogenesis either by directly inhibiting the activities of SUP-35/36/37 or through an indirect mechanism that somehow antagonizes the function of SUP-35/36/37. SUP-35/36/37 in turn antagonizes pharyngeal development in part by inhibiting pha-1 expression, but most importantly by acting through a distinct downstream target. Because SUP-35 and SUP-37 contain Zn fingers and can reside in the nucleus, the most likely function of SUP-35/36/37 involves transcriptional regulation. Given that PHA-1 is constitutively cytoplasmic, whereas SUP-35 translocates from the cytoplasm to the nucleus at the time of pharyngeal morphogenesis, it is possible that PHA-1 regulates the timing of SUP-35/36/37 translocation to the nucleus. In this model, unregulated access of SUP-35/ 36/37 to the nuclear compartment may lead to changes in transcription that are deleterious to embryonic development. We note, however, that we have not observed obvious effects of PHA-1 activity on the timing of SUP-35 translocation (D. S. Fay and S. R. G. Polley, unpublished data). Thus, PHA-1 may regulate the nuclear localization of SUP-36 or SUP-37, or may act through a different mechanism to regulate SUP-35/36/37 activity. Assaying for physical interactions between PHA-1 and SUP-35/36/37 as well as studies to determine whether PHA-1 plays a role in the timing of SUP-35/36/37 subcellular localization will be a focus of future efforts. Although SUP-35 and SUP-37 appear to act at a common step to regulate pharyngeal development, we note several important differences. Unlike SUP-35, overexpression of SUP-37 was not toxic in a wild-type background. Thus, if SUP-35 and SUP-37 were to function as components of a transcriptional regulatory complex, SUP-35 may be stoichiometrically limiting. Also in contrast to sup-35, sup-37 expression was not regulated by E2F-associated factors such as LIN-35/pRb and HCF-1 (Figure 8) . Consistent with this, sup-37 upstream regulatory sequences do not contain consensus bindings sites for E2F family members; nor have we previously detected alterations in sup-37 mRNA levels in lin-35 microarray experiments (Kirienko and Fay 2007) . In addition, sup-37 mRNA and SUP-37 protein levels were not affected by inhibition of UBC-18-ARI-1 activity, further suggesting that, unlike sup-35, sup-37 is not a common target of the LIN-35-EFL-1 and UBC-18-ARI-1 pathways.
SUP-37 also differs from SUP-35 in that it carries out essential postembryonic functions. Our evidence implicates SUP-37 within a small subset of pharyngeal muscle cell groups, termed pm3 and pm4, to facilitate normal pumping in L1 larvae. The specific requirement within these cells, however, appears to be somewhat flexible. Furthermore, SUP-37 must be present in at least some pm3 and pm4 cells for normal pumping to occur. The slow rate of contraction of the terminal bulb in the sup-37 mutant is interesting with respect to the failure of the corpus to contract. It is thought that the corpus is the source of a pharyngeal pacemaker that involves a pair of neurons, MCL and MCR. These neurons, however, cannot be the foci of sup-37, because they descend from ABa, not from MS, and the sup-37 feeding defect is worse than that which follows ablation of these neurons (Avery and Horvitz 1989) . We speculate that source of the pacemaker, although it requires the MC neurons, might be the rhythmic contractions of the corpus itself, and when they are impaired, the terminal bulb may undergo slow, default contractions.
In addition to pharyngeal pumping, SUP-37 is also required in the somatic gonad to promote ovulation. These functions suggest that SUP-37 may play a more general role in the regulation of myoepithelial tissues. Consistent with this, a role for SUP-37 in muscle development or function was previously suggested by a genome-wide bioinformatical analysis of cis-regulatory elements that are active in muscle cells (Zhao et al. 2007) . The mosaic analysis also raised the possibility that sup-37 has a nonessential function in the intestine. Notably, the intestine, the pharynx, and the somatic gonad share a common feature, rhythmic contractions, that are achieved via electrical coupling (Avery and Thomas 1997; McCarter et al. 1999; Nehrke et al. 2008; Altun et al. 2002 Altun et al. -2010 . Taken together, our data suggest that SUP-37 may play a role in promoting rhythmic contractions within an organ. Several pieces of data also indicate that the musclespecific functions of SUP-37 are independent of its role in regulating pharynx development with SUP-35 and PHA-1: (1) sup-35 null mutants are not defective in pharyngeal pumping or ovulation (Mani and Fay 2009 ); (2) overexpression of PHA-1 via extrachromosomal arrays does not lead to pharyngeal pumping or ovulation defects (Granato et al. 1994b) ; and (3) inactivation of pha-1 after embryogenesis, using a temperature-sensitive allele, does not lead to feeding or fertility defects (Schnabel and Schnabel 1990; Granato et al. 1994a; Fay et al. 2004) .
We also note that several other reports suggest additional biological roles for SUP-37. A genome-wide RNAi screen identified a clone corresponding to sup-37 as one of seven genes that are synthetically lethal in combination with loss of rap-1, which encodes a conserved small GTPase (Frische et al. 2007) . We note that we have verified this genetic interaction but did not observe pharyngeal defects in rap-1(tm861); sup-37(RNAi) mutants, nor does rap-1(RNAi) suppress pha-1(e2123ts) defects (D. S. Fay, unpublished observations). Thus, the functional overlap of SUP-37 and RAP-1 does not appear to be relevant to the role of SUP-37 in pharyngeal development. In addition, a study using chromatin-immunoprecipitation methods to identify DAF-16 targets indicates that SUP-37 may be a direct target for regulation by the DAF-2/IGF-DAF-16/FOXO pathway (Oh et al. 2006) . Consistent with this, the sup-37 genomic locus contains three consensus binding sites for DAF-16, and reduced sup-37 activity leads to a shortened lifespan and enhanced dauer formation. Thus, SUP-37 may control a set of diverse biological processes in addition to its roles in regulating pharyngeal development and function. LGQCFPAFFI DHPLPTRSDI EKLQILASGG DLKIGGIEKY LKEECEDGEP SEAPEDEEME EDDDGVSSD XXXXX -predicted Zn fingers XXXXX -region deleted in tm1083 XXXXX -region deleted in tm356 X -missense mutations X -insertion Figure S2 Amino acid sequences of wild--type and mutant forms of SUP--37/ZTF--12.
